Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.

In response to increasing abuse of prescription drugs, forty-four states have implemented--and five more states will soon adopt--monitoring programs to track prescriptions of controlled medications. Although these programs were originally designed to help law enforcement officials and regulatory agencies spot possible illegal activity, health care providers have begun to use data from them to help improve patient safety and quality of care. For this article we reviewed government documents, expert white papers, articles from the peer-reviewed medical literature, and reports of the experiences of local health officials. We found some evidence that prescription drug monitoring programs are a benefit to both law enforcement and health care delivery. However, the programs have strengths and weaknesses, and their overall impact on drug abuse and illegal activity remains unclear. We believe that improving the efficacy of prescription drug monitoring programs will require such changes as more standardization and interstate cooperation, better training of providers, more secure funding, and further evaluation.

[1]  Susan Okie,et al.  A flood of opioids, a rising tide of deaths. , 2010, The New England journal of medicine.

[2]  Bridget A. Martell,et al.  Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction , 2007, Annals of Internal Medicine.

[3]  P. Christo,et al.  The influence of prescription monitoring programs on chronic pain management. , 2009, Pain physician.

[4]  C. Marco,et al.  A statewide prescription monitoring program affects emergency department prescribing behaviors. , 2010, Annals of emergency medicine.

[5]  J. McAllister,et al.  Neonatal Abstinence Syndrome and Associated Health Care Expenditures , 2012 .

[6]  S. Schnoll,et al.  Do prescription monitoring programs impact state trends in opioid abuse/misuse? , 2012, Pain medicine.

[7]  Anna Lembke,et al.  Why doctors prescribe opioids to known opioid abusers. , 2012, The New England journal of medicine.

[8]  Marcia Valenstein,et al.  Association between Opioid Prescribing Patterns and Opioid Overdose-related Deaths Downloaded From: Http://jama.jamanetwork.com/ by a Penn State Milton S Hershey Med Ctr User on 08/01/2013 , 2022 .

[9]  Leonard J Paulozzi,et al.  Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.

[10]  E. Bruera,et al.  Critical issues on opioids in chronic non-cancer pain: An epidemiological study , 2006, Pain.

[11]  Christopher M. Jones,et al.  Prescription drug monitoring programs-lack of effectiveness or a call to action? , 2011, Pain medicine.

[12]  Hassan Baxi,et al.  Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes. , 2012, The journal of pain : official journal of the American Pain Society.

[13]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.

[14]  P. Friedmann,et al.  Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose". , 2011, Pain medicine.

[15]  J. McAllister,et al.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. , 2012, JAMA.

[16]  J. Freburger,et al.  A Long Way to Go: Practice Patterns and Evidence in Chronic Low Back Pain Care , 2009, Spine.

[17]  Marlon P Mundt,et al.  Substance use disorders in a primary care sample receiving daily opioid therapy. , 2007, The journal of pain : official journal of the American Pain Society.

[18]  Seth A. Berkowitz,et al.  Opioids for chronic pain. , 2011, Archives of internal medicine.

[19]  Lewis S. Nelson,et al.  Prescribing Practices, Knowledge, and Use of Prescription Drug Monitoring Programs (PDMP) by a National Sample of Medical Toxicologists, 2012 , 2012, Journal of Medical Toxicology.

[20]  D. Juurlink,et al.  Facing up to the prescription opioid crisis , 2011, British medical journal.

[21]  D. Brushwood Maximizing the Value of Electronic Prescription Monitoring Programs , 2003, Journal of Law, Medicine & Ethics.

[22]  R. Chou,et al.  Long-Term Opioid Therapy Reconsidered , 2011, Annals of Internal Medicine.

[23]  S. Fishman,et al.  Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. , 2004, Pain medicine.

[24]  C. Marco,et al.  43: How Does Use of a Statewide Prescription Monitoring Program Affect Emergency Department Prescribing Behaviors? , 2009 .

[25]  S. Fishman Commentary in response to Paulozzi et al.: prescription drug abuse and safe pain management , 2006, Pharmacoepidemiology and drug safety.

[26]  Peter Jüni,et al.  Oral or transdermal opioids for osteoarthritis of the knee or hip. , 2014, The Cochrane database of systematic reviews.

[27]  Grant M. Carrow,et al.  Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. , 2008, Pain medicine.